Skip to main content
. 2018 May 8;2018:6930297. doi: 10.1155/2018/6930297

Figure 3.

Figure 3

A schematic picture on screening and monitoring rheumatic disease associated lung involvements. DLCO: diffusing capacity of carbon monoxide; FVC: forced vital capacity; HRTC: high resolution computed tomography; ILD: interstitial lung disease; NT-proBNP: N-terminal probrain natriuretic peptide; PAH: pulmonary arterial hypertension; TR: tricuspid regurgitation.